General medical journalCurrentRheuma coverage
New England Journal of Medicine
What CurrentRheuma has captured from this journal. The coverage figures describe CurrentRheuma's coverage, not the journal's output. Figures as of 14 November 2026.
CurrentRheuma holds 21 Briefs from New England Journal of Medicine, most often randomized controlled trials and other research.
Follow all of it, or only:You follow this. See your week →Explore N Engl J Med with filters →
- Recent
- 2 Briefs
- past 90 days
- Archive
- 21 Briefs
- research published Oct 2025 – today, Oct 2024 – Jun 2025, Oct 2023 – Jun 2024 and Apr–Jun 2023
- Editorial
- –
- no Weekly issue published yet
Topics
Evidence types
- Randomized controlled trials1781.0%
- Secondary analyses14.8%
- Cohort studies14.8%
- Cross-sectional studies14.8%
- Other research14.8%
Shares are of the 21 Briefs CurrentRheuma has covered from N Engl J Med, by primary topic and study type.
Publication activity
- 20267 Briefs
- 20255 Briefs
- 20247 Briefs
- 20232 Briefs
Latest from New England Journal of Medicine
N Engl J Med
Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity
Research articleOsteoarthritis
N Engl J Med
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
Randomized controlled trialOsteoarthritis
N Engl J Med
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
Randomized controlled trialVasculitis & PMR
N Engl J Med
Obexelimab for the Treatment of IgG4-Related Disease
Randomized controlled trialAutoinflammatory & rare
N Engl J Med
Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease
Randomized controlled trialPediatric
N Engl J Med
A Phase 3 Trial of Brepocitinib in Dermatomyositis
Randomized controlled trialMyositis
N Engl J Med
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
Randomized controlled trialLupus & APS
N Engl J Med
A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain
Randomized controlled trialOsteoarthritis
N Engl J Med
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
Randomized controlled trialLupus & APS
N Engl J Med
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Randomized controlled trialVasculitis & PMR
N Engl J Med
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Randomized controlled trialLupus & APS
N Engl J Med
Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age
Randomized controlled trialOsteoporosis
N Engl J Med
Inebilizumab for Treatment of IgG4-Related Disease
Randomized controlled trialAutoinflammatory & rare
N Engl J Med
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Randomized controlled trialOsteoarthritis
N Engl J Med
Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis
Randomized controlled trialOsteoarthritis
N Engl J Med
Autoantibodies Targeting Nephrin in Podocytopathies
Cross-sectional studyPediatric
N Engl J Med
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Randomized controlled trialVasculitis & PMR
N Engl J Med
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Cohort studyLupus & APS
N Engl J Med
Testosterone Treatment and Fractures in Men with Hypogonadism
Secondary analysisOsteoporosis
N Engl J Med
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Randomized controlled trialVasculitis & PMR
N Engl J Med
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Randomized controlled trialRA